Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
100 participants
OBSERVATIONAL
2014-01-31
2015-02-28
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
PMCF 8 Year Results TRJ®
NCT04542174
Post Market Clinical Follow-Up of Acetabular Titan-Augment Structan®
NCT02019433
Cemented TrendHip® - Multicenter PMCF Study on Total Indications
NCT04943328
Post Market Clinical Follow-Up Study of Excia T® Hip Prosthesis
NCT02188095
Post Market Clinical Follow-up of EUROSTEM Femoral Stem
NCT04995822
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
RETROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
TRJ®
TRJ® Total Hip Arthroplasty
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
TRJ® Total Hip Arthroplasty
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* patient consent available for participation in the study
Exclusion:
* permanent cortisone therapy
* alcohol or drug abuse
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Aesculap AG
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Dreifaltigkeitskrankenhaus Köln
Cologne, , Germany
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
AAG-O-H-1314
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.